Bibliographic information
GuidelineLiving guidance for clinical management of COVID-19: living guidance, 23 November 2021.
Year of Publication2021
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
Originally developed
In hospitalized children aged 0–18 who meet a standard case definition for multisystem inflammatory syndrome (MIS-C) and diagnostic criteria for Kawasaki disease, we suggest using corticosteroids in addition to standard of care for Kawasaki disease
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Clinical management of COVID-19: living guideline, 23 June 2022.
Year2022
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 15 September 2022.
Year2022
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 13 January 2023.
Year2023
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 18 August 2023
Year2023
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, June 2025
Year2025
InstitutionWorld Health Organization